(COMBO) This combination of pictures created on August 19, 2026 shows the Moderna logo at their headquarters on May 8, 2020 in Cambridge, Massachusetts and the Merck logo at their headquarters on February 5, 2024 in Rahway, New Jersey. US drugmakers Merck and Moderna said on August 19, 2026, an experimental melanoma drug that delivers treatment tailored to a patient's specific tumor prevented the cancer from returning in a large clinical trial. Called "intismeran autogene," it is based on the same messenger ribonucleic acid technology behind Covid-19 vaccines. Researchers have been working on developing mRNA treatments against cancer, but this is the first time one has shown positive results in a Phase 3 trial.,Image: 1125721961, License: Rights-managed, Restrictions: , Model Release: no
11.09.2021., Sibenik - Cjepivo protiv koronavirusa. Moderna. rPhoto: Dusko Jaramaz/PIXSELL
